Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: faq + genetics + faqs  Related to the article below (Last Update: 8/4/2008)

Researchers Face Jail Risk For Tor Snooping Study
Slashdot - Jul 24, 2008
Regardless of FAQ containing legal advice to the contrary. They sought minimal outside advice, and may or may not have provided enough information for the ...
Researchers Face Jail Risk For Tor Snooping Study Slashdot
all 3 news articles »
GeneTree Adds Y-Chromosome DNA Testing Option to Trace Paternal ...
MarketWatch - Jul 21, 2008
The GeneTree.com online pressroom is located at www.genetree.com/help/pressroom.html, and provides high-resolution images, FAQs, backgrounder and product ...
Source: Google News

Male Pseudohermaphroditism Due to Steroid 5 alpha-Reductase 2 Deficiency: Diagnosis, Psychological … -
… , EMF COSTA, IVOJP ARNHOLD, FAQ SILVA, W NICOLAU, … - Medicine, 1996 - md-journal.com
... From the Gonads and Intersex Unit (BBM, MI, EMFC, IJPA, FAQS, WN, WB ... School of Medicine,
Sao Paulo, Brazil and the Departments of Molecular Genetics (DWR) and ...

[BOOK] Advances in Genetic Programming -
KE Kinnear, PJ Angeline - 1994 - books.google.com
... Chapter 3 increases our theoretical understanding of genetic programming through
the use of analysis techniques drawn from population genetics. ...

Potent and specific genetic interference mediated by double-stranded RNA in Caenorhabditis elegans -
A Fire, S Xu, MK Montgomery, S Kostas, S Driver, C … - Nature, 1998 - works.bepress.com
... nematodes. Courses/Seminars. Cell Biology and Genetics; Developmental Biology;
Biotechnology and Society; Research in Molecular Biology. ...

Male Pseudohermaphroditism due to 17 [beta]-Hydroxysteroid Dehydrogenase 3 Deficiency: Diagnosis, … -
… , RM Martin, FT Denes, FAQ Silva, S Andersson, A … - Medicine, 2000 - md-journal.com
... and Division of Urology (FTD, FAQS), Hospital das ... Diagnosis, phenotypic variability,
population genetics and worldwide ... EMF, Arnhold IJP, Silva FAQ, Nicolau W ...

Parallel object-oriented library of genetic algorithms -
M Bubak, W Ciesla, K Sowa - Proceedings of the Third International Workshop - Springer
... (ftp://rtfm.mit.edu/pub/usenet/news.answers/ai-faq/genetic/) 9. JR Filho, C. Alippi,
P. Treleaven, "Genetic Algorithm Programming Environ- ments", Department ...

Genetic algorithms: concepts and applications [in engineeringdesign]
KF Man, KS Tang, S Kwong - Industrial Electronics, IEEE Transactions on, 1996 - ieeexplore.ieee.org
... The Hitch-Hiker's Guide to Evolutionary Computation: A list of Frequently Asked
Questions (FAQ)., (1994), [Online]. Available: USENET:comp.ai.genetic.. ...

PCR primers for microsatellite loci in tuna species of the genus Thunnus and its application for … -
M Takagi, T Okamura, S Chow, N Taniguchi - Fisheries Science, 1999 - sciencelinks.jp
PCR Primers for Microsatellite Loci in Tuna Species of the Genus Thunnus and its
Application for Population Genetic Study. Accession number;99A0772615. ...
-

Unintended Messages: The Ethics of Teaching Genetic Dilemmas. -
HC Gooding, B Wilfond, K Boehm, BB Biesecker - The Hastings Center Report, 2002 - questia.com
... www.beavercreek.k12.oh.us/bhs/mcdaniel /genecounsel.htm (2000); and DE Wilcox,
"University of Glasgow, Department of Medical Genetics, Students' FAQ Page," http ...

… complex, NAD (P) H dehydrogenase in chloroplasts: dissection by chloroplast reverse genetics
T Shikanai, T Endo - Plant Biotechnol, 2000 - sciencelinks.jp
... Dissection by Chloroplast Reverse Genetics. Physiological ... Chloroplasts. Dissection
by Chloroplast Reverse Genetics. Accession number;00A0566707. ...
-

[CITATION] 1999. Cat Colors FAQ: Cat Color Genetics. Website
O Starbuck, D Thomas

Source: Google Scholar
 

Genetics FAQ

What Are Genetic Disorders?

A genetic disorder is a disease caused in whole or in part by a "variation" (a different form) or "mutation" (alteration) of a gene. As we unlock the secrets of the human genome, we are learning that nearly all diseases have a genetic component. Some, including many cancers, are caused by a mutation in a gene or group of genes in the cells of an individual. Such mutations can occur randomly or due to some environmental exposure (such as cigarette smoke). Other genetic disorders are hereditary — such as Huntington's disease or Marfan's disease — where a mutated gene is passed down through a family and each generation of children can inherit the gene that causes the disease.

But most genetic disorders are "multifactorial inheritance disorders," meaning they are caused by a combination of small variations in genes, often in concert with environmental factors.

Article continues below and (thank you)

 

Through research on the human genome, we now know that many common diseases usually caused by genetic alterations in the genes of an individual's cells — such as breast cancer and colon cancer — also have rare hereditary forms. In these cases, gene variants that cause or strongly predispose a person to these cancers run in a family and significantly increase each member's risk of developing the disease.

Geneticists group genetic disorders into three categories:

  • Single gene disorders are caused by a mutation in a single gene. The mutation may be present on one or both chromosomes (one chromosome inherited from each parent). Sickle cell disease, cystic fibrosis and Tay-Sachs disease are examples of single gene disorders.

  • Chromosome disorders are caused by an excess or deficiency of the genes that are located on chromosomes, or structural changes within chromosomes. Down syndrome, for example, is caused by an extra copy of chromosome 21, but no individual gene on the chromosome is abnormal.

  • Multifactorial inheritance disorders are caused by a combination of small variations in genes, often in concert with environmental factors. Heart disease and most cancers are examples of these disorders. Behaviors are multifactorial, complex traits involving multiple genes that are affected by a variety of other factors. Researchers are learning more about the genetic contribution to behavioral disorders such as alcoholism, obesity, mental illness and Alzheimer disease. There is currently no recommended genetic testing for behavioral disorders such as alcoholism or obesity.
What Is Genetic Testing?

Genetic tests look for alterations in a person's genes or changes in the level of key proteins coded for by specific genes. Abnormal results on these tests could mean that someone has an inherited disorder.

Types of genetic tests include:

  • Gene tests (when you test DNA)
  • Chromosomal tests (called karyotype and FISH)
  • Biochemical tests (when you test enzyme levels)
What Is a Gene Test?

Gene tests look for signs of a disease or disorder in DNA taken from a person's blood, body fluids or tissues. The tests can look for large changes, such as a gene that has a section missing or added, or small changes, such as a missing, added or altered chemical base within the DNA strand. Other important changes can be genes with too many copies, genes that are too active, genes that are turned off or those that are lost entirely.

Gene tests examine a person's DNA in a variety of ways. Some tests use probes. These are short strings of DNA with base sequences complementary to those of an altered gene. Probes look for their complements within a person's genome. If the altered is found, the probe binds to it, identifying the alteration.

Another type of gene test directly compares the sequence of DNA bases in a patient's gene to a normal version of the gene.

What Is a Chromosomal Test?

Chromosomes are structures in the nucleus of a cell that contain DNA. Chromosomal tests look at features of a person's chromosomes, including their structure, number and arrangement. These tests look for changes, such as pieces of chromosomes being switched or being in a different location.

Types of chromosomal tests include:

  • Karyotype — This test gives a picture of all of a person's chromosomes from the largest to the smallest.

  • FISH analysis (fluorescent in situ hybridization) — This test identifies certain regions on chromosomes using fluorescent DNA probes. FISH analysis can find small pieces of chromosomes that are missing or have extra copies. These small changes can be missed by the karyotype test.
What Is a Biochemical Test?

Biochemical tests look at the level of key proteins. This level signals genes that are not working normally. These types of tests are used for newborn screening. For example, this screening can detect infants who have metabolic conditions such as phenylketonuria (PKU).

What Information Can Genetic Testing Give?

Genetic testing can:

  • Give a diagnosis if someone has symptoms.

  • Show whether a person is a carrier for a genetic disease. Carriers have an altered gene, but will not get the disease. However, they can pass the altered gene on to their children.

  • Help expectant parents know whether an unborn child will have a genetic condition. This is called prenatal testing.

  • Screen newborn infants for abnormal or missing proteins that can cause disease. This is called newborn screening.

  • Show whether a person has an inherited disposition to a certain disease before symptoms start.

  • Determine the type or dose of a medicine that is best for a certain person. This is called pharmacogenetics.
People in families at high risk for a genetic disease have to live with uncertainty about their future and their children's future. A genetic test result that can show that a known alteration causing disease is not present in a person can provide a sense of relief.

A genetic test result that shows a person has an alteration causing disease also can give benefits. Such a test result might lead a person to take steps to lower their chance of disease. For example, someone could screen for the disease or could make changes to their health habits like diet and exercise. A genetic test result showing that a person has an alteration causing disease can lower their uncertainty. This information also can help people to make informed choices about their future.

What Are Reasons to Get Different Types of Genetic Tests?

Diagnostic testing is to confirm a diagnosis when a person has signs or symptoms of a genetic disease. The genetic test used depends on the disease for which a person is tested. For example, if a patient has physical features that suggest Down syndrome, a chromosomal test is used. To test for Duchenne muscular dystrophy, a gene test is done to look for missing sections in the dystrophin gene.

Predictive testing can show which people have a higher chance of getting a disease before symptoms appear. For example, one type of predictive test screens for inherited disposition to certain cancers, such as colon and breast cancer. Someone with an inherited disposition has an increased chance of getting a disease. This does not mean that the person will certainly get the disease.

Presymptomatic testing shows which family members are at risk for a certain genetic condition. This type of testing is done with people who do not have symptoms when the alteration causing disease in the family is known. For some diseases, this type of testing can lead to prevention or treatment options. For example, when a disease-causing alteration is found in a family, testing is recommended for all close blood relatives (such as parents and siblings). Those family members with the alteration can be offered removal of the thyroid. With other types of diseases, there are no prevention or treatment options. For example, there is no treatment for family members who have an alteration causing Huntington's disease and those who have this alteration are certain to get the disease.

Carrier testing can tell individuals if they are carriers of a gene alteration for a type of inherited disorder called an autosomal recessive disorder. A person who has only one altered copy of a gene for this type of disorder is called a carrier. Carriers will not get the disease, but can pass on the alteration to their children. If both parents are carriers, their children might inherit an alteration from each parent and get the disease. Examples of this type of disorder are cystic fibrosis and Tay-Sachs.

Prenatal testing is available to pregnant women:

  • Who are age 35 or older. This is because they are at higher risk for having a child with a chromosomal abnormality.

  • Who have a family history of an inherited condition such as Duchenne muscular dystrophy.

  • When their ancestry or ethnic background means that they might have a higher chance of an inherited disorder such as sickle cell anemia, thalassemia or Tay-Sachs disease.

  • To screen for common genetic disorders such as spina bifida and Down syndrome.
Two diagnostic procedures are common in prenatal testing. Amniocentesis involves testing a sample of amniotic fluid from the womb. CVS (or chorionic villus sampling) involves taking a tiny tissue sample from outside the sac where the fetus grows.
  • Newborn screening is the most widespread type of genetic testing. It is an important public health program that can find disorders in newborns that have long-term health effects. Newborn screening tests infant blood samples for abnormal or missing gene products. For example, infants are often screened for Phenylketonuria (PKU). This is an enzyme deficiency that can lead to severe mental retardation if the child is not treated. Newborn screening now tests for more diseases. In the past, newborn screening focused on a few metabolic disorders that led to mental retardation. Newborn screening programs now test for disorders that can cause infectious disease, premature death, hearing disorders and heart problems. A new technology called tandem mass spectrometry allows screening of up to 30 other metabolic disorders. The number of disorders screened for varies from state to state. Some states offer newborn screening for up to 30 diseases, while others offer newborn screening for the most common disorders.

  • Pharmacogenetic testing is a new type of genetic testing. This type of test examines a person's genes to look at how drugs would move through the body and be broken down. The goal of pharmacogenetic testing is to have drug treatments that are specific to each person. For example, a test used in patients who have chronic myelogenous leukemia can show which patients would benefit from a medicine called Gleevac. Another test looks at a liver enzyme called cytochrome P450, which breaks down certain types of drugs. Gene alterations can affect how well people's bodies break down certain drugs. People with a less active form of the enzyme might get too much of a drug. Pharmacogenetic testing can help make sure that people get the right amount of a medicine.
How Do I Decide Whether to Be Tested?

People have many different reasons for being tested or not being tested. For many, it is important to know whether a disease can be prevented if a gene alteration causing a disease is found. For example, those who have inherited forms of breast or colon cancer have options such as screening or early treatment. Pharmacogenetic testing can find the best medicine or dose of a medicine for a certain person.

In other cases, there is no treatment. There are no preventive steps or cures for Huntington's disease. But test results might help a person make life decisions, such as career choice, family planning or insurance coverage.

People can seek advice from a genetic counselor. Genetic counselors help individuals and families think about the scientific, emotional and ethical factors that affect the testing decision.

What About Direct-to-Consumer Genetic Tests Available on the Internet?

A number of companies offer self-administered genetic tests for many different reasons. Genetic testing offered via the Internet usually uses a cell sample scraped from inside the cheek, which is mailed to a test laboratory. One type of test offered, called nutrigenetic testing, says that it will match an individual's diet with their genetic make-up.

A recent report issued by the Government Accountability Office found that these tests can be misleading to consumers because they make predictions that cannot be scientifically proven. Furthermore, these tests may not provide meaningful information and could even provide harmful information to consumers.

Other types of self-administered genetic testing offered on the Internet include those for specific diseases (cancer, Alzheimer's disease) and genetic tests that can help trace family background and ancestry. These tests also may be misleading to consumers.

Before using genetic tests offered on the Internet, you should check with a genetic professional about the genetic test of interest.

Updated: January 2007

Source: National Human Genome Research Institute, National Institutes of Health

 

Genetics

Genetics includes the study of how human characteristics are inherited from one's parents. It explains how traits as simple as eye color or as complex as susceptibility to diseases run in families. Genes are units of heredity passed from parents to offspring and are contained in a person's cells — every human cell contains approximately 30,000 genes. Genes vary greatly from person to person and influence personality, intelligence, physical appearance, and other traits to a certain extent, but learning and environment play an important role as well. The November 14, 2001 , issue of JAMA is dedicated to genetics.

Genetics Terminology

  • DNA (deoxyribonucleic acid) is the chemical inside a gene that carries genetic instructions for making living things. DNA is made of two long, twisting molecules called "the double helix."
  • Chromosomes are packets of genes in a cell. Humans have 23 pairs (46 total). One member of each pair of chromosomes is inherited from the mother, and the other from the father. Two of the 46 chromosomes (X, Y) are sex chromosomes that determine whether offspring will be male or female. Individuals with a pair of X chromosomes are female and those with an X chromosome and a Y chromosome are male.
  • A genome is an entire system of genes. Genomics is the study of how genes interact and influence the biology and physical characteristics of living things.
  • Mutations are changes in DNA. These changes are sometimes passed on to offspring.
  • Genetic disorders are diseases or disorders caused by gene mutations or chromosomal defects.

Genetic Disorders and Inheritance

Heritability is the degree to which a characteristic is determined by a person's genes. Many diseases have a genetic cause. Types of genetic disorders are described below.

  • Familial disorders are those that affect more than one person in a family. There are times, however, when a child is born with an unexpected genetic disorder without a known family history of the disorder.
  • Chromosome abnormalities can cause some genetic disorders, which occur when a child is born with an abnormal number of chromosomes or extra or missing pieces of chromosomes.
  • Unifactorial diseases can occur when certain defects in a gene or a pair of genes are present. Sickle-cell anemia and cystic fibrosis are two examples of unifactorial diseases.
  • Multifactorial diseases are those that involve a number of different genes that, combined with environmental factors, can cause disorders such as asthma and diabetes.

If you or your partner is concerned about a disorder that seems to run in either of your families, you may want to see a genetic counselor before having children. You can often be tested to see if your or your partner's genes carry certain disorders.

Centers for Disease Control and Prevention
(800) 311-3435
www.cdc.gov/genetics/info.htm

National Human Genome Research Institute (National Institutes of Health)
www.nhgri.nih.gov/DIR/VIP/Glossary

Public Health Genetics Unit ( University of Cambridge )
www.medinfo.cam.ac.uk/phgu/info_database/glossary.asp

Inform Yourself

To find this and previous JAMA Patient Pages, go to the Patient Page Index on JAMA's Web site at www.jama.com.

Sources: American Medical Association Encyclopedia of Medicine, American Medical Association Family Medical Guide, Centers for Disease Control and Prevention, Human Genetics Programme (World Health Organization), National Human Genome Research Institute, Public Health Genetics Unit

Lise M. Stevens, M.A., Writer
Cassio Lynm, M.A., Illustrator
Richard M. Glass, M.D., Editor

(JAMA. 2001; 286:2354)

Published in JAMA: November 14, 2001

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be reproduced noncommercially by physicians and other health care professionals to share with patients. Any other reproduction is subject to AMA approval. To purchase bulk reprints, call (718) 946-7424.

 

©Copyright 2001 American Medical Association. All rights reserved.

 

Vaccine Reduces Serious Illness Among Children With Sickle Cell Disease


A vaccine introduced in 2000 has reduced by more than 90 percent the rate of a serious bacteial illness among young children with sickle cell disease (SCD), who are particularly susceptible to it, according to a new study that appears in the June 1 issue of Clinical Infectious Diseases and currently is available online.

SCD is an inherited blood disorder that affects red blood cells, sometimes turning these cells crescent-shaped. The deformed cells can get stuck in small blood vessels, creating blockages that can reduce blood flow. SCD can cause painful episodes and strokes, and can damage organs including the lungs, kidneys, liver, and spleen. The average life expectancy of someone with SCD is in the mid-40s. In the United States, it is estimated that more than 70,000 people are living with SCD and about 1,000 babies are born with this condition each year.

Diseases caused by a bacterium known as pneumococcus are a leading cause of death among children with SCD. People with SCD are between 30 and 600 times more likely to develop pneumococcal meningitis, bloodstream infections, and other serious infections, compared to individuals of comparable age and race without SCD.

The new study, by Natasha Halasa, MD, MPH, of Vanderbilt University's School of Medicine and colleagues, looked at pneumococcal disease rates among young children with SCD in Tennessee's Medicaid program before and after the introduction in 2000 of the pneumococcal conjugate vaccine (PCV). They found the rate of serious pneumococcal disease dropped by more than 90 percent among children under 5 years of age.

"I was not surprised that there was a decrease," Dr. Halasa said, "just surprised about the magnitude of the decrease."

Since its introduction in 2000, PCV has been recommended for all children younger than 2 years of age, and for selected children 2 to 4 years with certain high-risk conditions, including SCD. The authors write: "With the universal administration of PCV to all children, both with and without SCD, it is expected that the rates of invasive pneumococcal disease (IPD) will continue to decline in all children."

Dr. Halasa did express concern, however, that other strains of pneumococcus besides the seven included in the vaccine might become more common, thus renewing the threat of IPD. For this reason, she said, monitoring for IPD should continue in all populations, including those who are at high-risk for IPD, such as those with SCD or HIV.

Fast Facts:

* Sickle cell disease (SCD) is an inherited blood disorder that affects more than 70,000 people in the United States.

* Infections with the pneumococcus bacterium are a leading cause of death among people with SCD.

* This study shows that rates of serious pneumococcal infections fell by 90 percent after the introduction of the pneumococcal conjugate vaccine in 2000.

###

Founded in 1979, Clinical Infectious Diseases publishes clinical articles twice monthly in a variety of areas of infectious disease, and is one of the most highly regarded journals in this specialty. It is published under the auspices of the Infectious Diseases Society of America (IDSA). Based in Alexandria, Va., IDSA is a professional society representing more than 8,000 physicians and scientists who specialize in infectious diseases. For more information, visit http://www.idsociety.org/.

Contact: Steve Baragona
Infectious Diseases Society of America

 

 
Google
Web www.iconocast.com
 
 
Source for News : URL: http://www.medicalnewstoday.com and Reuters
Continue News With: News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

 © 2002-2006

Keywords:

Contact Iconocast